BLT Fund9 Bethesdan, LLC

BLT Fund9 Bethesdan, LLC, a for-profit limited liability company based in Bethesda, Maryland, operates as a prime contractor providing hotel accommodations and conference support services to the National Institutes of Health system. The company competes exclusively full-and-open, with no small-business set-asides across its federal footprint. BLT Fund9 Bethesdan delivers concrete hospitality and logistics services: temporary lodging for NIH patients and authorized family members participating in clinical research studies, hotel and conference space for NIH peer review meetings where independent scientists evaluate extramural grant applications, audiovisual equipment rental, and limited transportation services—all performed on-demand and primarily in Bethesda, Maryland.

The vendor's customer base is heavily concentrated within the NIH system. The top three NIH funding sources account for 98% of awards and 99% of combined potential value. The NIH Clinical Center leads by transaction volume with 153 awards ($4.2 million combined potential value) for patient lodging and clinical center support. The NIH Center for Scientific Review placed 98 awards ($1.6 million combined potential value) for peer review meeting logistics. The NIH Office of Logistics and Acquisition Operations, though representing only 16 awards, anchors 80% of the vendor's total potential value at $25 million—a substantial recompete cliff signal. The Navy Installations Command represents a $483 thousand outlier purchase order from October 2025 for lodging and applicable taxes.

BLT Fund9 Bethesdan holds two indefinite-delivery vehicles. The larger is a five-year, $10 million ceiling single-award Blanket Purchase Agreement with the NIH Office of Logistics and Acquisition Operations, awarded September 22, 2022, through December 31, 2027, authorizing task orders for hotels (except casino hotels), motels, conference room space, and audiovisual equipment rental across NIH institutes and centers. Recent activity under this BPA has been steady: 99 task orders with combined potential value of $1.7 million, individual calls ranging from $3,761 to $46,020, with typical peer review orders supporting three-to-seven-day meetings. The second vehicle is a single-award indefinite-delivery contract with the NIH Clinical Center awarded August 1, 2026, with a ceiling of $24.6 million and ultimate completion July 31, 2027, for patient lodging, family/guardian accommodations, and peer review meeting support in Bethesda. That IDC ceiling has not been operationalized across the award snapshot; to date, activity under it reflects modest early ordering.

Activity has grown sharply year over year. In 2022, the vendor recorded 20 awards; by 2023 that grew to 96; 2024 peaked at 110 awards. Activity has moderated in 2025–2026 (31 and 17 awards respectively), reflecting maturity in the customer ordering pattern and potential pipeline management. Sixteen awards carrying $25 million in combined potential value complete through December 31, 2027, representing significant recompete and renewal exposure.

The vendor's footprint is exclusively prime—all 283 awards are prime contracts or IDVs with zero subcontract activity. NAICS classification is 99% concentrated in 721110 (Hotels except Casino Hotels and Motels), with 281 of 283 awards. PSC codes show 138 awards under Transportation/Travel/Lodging (Port Operations), 111 under Lease/Rental of Conference Space and Facilities, reflecting the hybrid nature of the work. Work is performed entirely in Bethesda, Maryland.

BLT Fund9 Bethesdan operates on a high-velocity, low-dollar-per-order model: individual purchase orders and BPA task orders typically range from $5,000 to $50,000, with completion dates measured in days to weeks. The combined obligated value across all 283 awards is $5.9 million (19% of combined potential), indicating that many awards are standing offers rather than fully consumed. The vendor's business model reflects on-demand hospitality logistics—no backlog, no inventory, high customer retention within the NIH system, and minimal competitive pressure from alternative providers given local placement and relationship depth.